Brimonidine Impurity 2

Product Description
CAT No.
ALN-B026024
CAS No.
NA
Mol. F.
C22H18Br2N10
Mol. Wt.
582.3
Stock
Please Inquire
Product Overview
Technical Data
Reference
RFQ
Product Overview
Chemical Name : N2-(5-Bromoquinoxalin-6-yl)-N2′-(7-bromoquinoxalin-6-yl)-4,4′,5,5′-tetrahydro-[1,1′-biimidazole]-2,2′-diamine
Smiles : BrC1=C(NC2=NCCN2N3CCN=C3NC4=CC(N=CC=N5)=C5C=C4Br)C=CC6=C1N=CC=N6
Technical Data
Reference
Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma
B.Chianga1Y.C.Kimb1A.C.Dotyc12H.E.GrossniklausdS.P.SchwendemancM.R.PrausnitznJournal of Controlled Release Volume 228, 28 April 2016, Pages 48-57
Sustained release of brimonidine from a new composite drug delivery system for treatment of glaucoma
Jianguo Sun, Yuan Lei, Zhaoxing Dai∥, Xi Liu, Taomin Huang, Jihong Wu, Zhi Ping XOrcid, and Xinghuai Sun – ACS Appl. Mater. Interfaces 2017, 9, 9, 7990–7999
A validated stability-indicating HPLC method for determination of brimonidine tartrate in BRI/PHEMA drug delivery systems
Jianguo Sun, Xiuwen Zhang & Taomin Huang – Chemistry Central Journal volume 11, Article number: 62 (2017)
RFQ